Similar articles

• [BSE, prions, vCJD and (not only) homologous transfusion].

  Köhler M. Köhler M. Anasthesiol Intensivmed Notfallmed Schmerzther. 2003 Jan;38(1):43-7. doi: 10.1055/s-2003-36564. Anasthesiol Intensivmed Notfallmed Schmerzther. 2003. PMID: 12522730 Review. German. No abstract available.
• Removal of TSE agents from blood products.

  Foster PR. Foster PR. Vox Sang. 2004 Jul;87 Suppl 2:7-10. doi: 10.1111/j.1741-6892.2004.00444.x. Vox Sang. 2004. PMID: 15209867 Review. No abstract available.
• Prion diseases.

  Knight R. Knight R. Vox Sang. 2004 Jul;87 Suppl1:104-6. doi: 10.1111/j.1741-6892.2004.00504.x. Vox Sang. 2004. PMID: 15200617 Review. No abstract available.
• Creutzfeldt-Jakob disease and blood transfusion.

  Fernandez Lopez MJ, Van Everbroeck B, Pals P, Martin JJ, Cras P. Fernandez Lopez MJ, et al. Acta Neurol Belg. 1998 Sep;98(3):247-51. Acta Neurol Belg. 1998. PMID: 9801705 Review.
• Transfusion transmission of human prion diseases.

  Zou S, Fang CT, Schonberger LB. Zou S, et al. Transfus Med Rev. 2008 Jan;22(1):58-69. doi: 10.1016/j.tmrv.2007.09.003. Transfus Med Rev. 2008. PMID: 18063192 Review.